BACKROUND: Only few therapeutic options exist for patients with refractory sudden idiopathic sensorineural hearing loss (SISHL). Little is known about the efficacy of second-line therapies. Rheopheresis seems to be an effective therapeutic possibility. METHODS: Between 2012 and 2015, 106 patients with SISHL were enrolled in the study, of whom 52 were refractory to initial treatment. As salvage therapy, these patients were offered either 3 sessions of rheopheresis (33 pts) or intratympanic steroid treatment through MicroWick application (19 pts). Pure tone audiometry was performed at diagnosis, at the 1st month and the 1st year during the follow-up. RESULTS: Patients in the rheopheretic arm had higher hearing loss than in the MicroWick arm (81% vs. 52%, p = 0.04). In spite of this, there was a significant improvement for patients in the rheopheretic arm (27% of hearing loss reduction, p < 0.001) after the 1st month and this remained unchanged during the 1st year, while no improvement was seen in the MicroWick arm (0% of hearing loss reduction, p = 0.424). We found no predictive factor for steroid-failure in first-line therapy. Older age (p = 0.003), presence of vertigo (p = 0.006) and more profound initial hearing loss (p < 0.001) were identified as negative prognostic markers. CONCLUSION: Rheopheresis can be used as a potentially effective and safe salvage therapy for patients with cortico-refractory SISHL.

4th Department of Internal Medicine University Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Králové Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Králové Czech Republic

See more in PubMed

Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the sixth special issue. J Clin Apher. 2013;28:145–284. doi: 10.1002/jca.21276. PubMed DOI

Klemm E, Deutscher A, Mosges R. A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngorhinootologie. 2009;88:524–527. doi: 10.1055/s-0028-1128133. PubMed DOI

Atay G, Kayahan B, Cinar BC, Sarac S, Sennaroglu L. Prognostic factors in sudden sensorineural hearing loss. Balkan Med J. 2016;33:87–93. doi: 10.5152/balkanmedj.2015.15216. PubMed DOI PMC

Zarandy M, Rutka J. Diseases of the inner ear. Berlin Heidelberg: Springer Verlag; 2010.

Lazarini PR, Camargo AC. Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects. Braz J Otorhinolaryngol. 2006;72:554–561. doi: 10.1016/S1808-8694(15)31004-1. PubMed DOI PMC

Selmani Z, Pyykko I, Ishizaki H, Marttila TI. Cochlear blood flow measurement in patients with Meniere’s disease and other inner ear disorders. Acta Otolaryngol Suppl. 2001;545:10–13. doi: 10.1080/000164801750388027. PubMed DOI

Mosges R, Koberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W. Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol. 2009;266:943–953. doi: 10.1007/s00405-008-0823-5. PubMed DOI

Schillaci G, Pirro M, Vaudo G, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol. 2004;43:1817–1822. doi: 10.1016/j.jacc.2003.12.049. PubMed DOI

Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol. 1994;114:601–607. doi: 10.3109/00016489409126112. PubMed DOI

Suckfull M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet (London, England) 2002;360:1811–1817. doi: 10.1016/S0140-6736(02)11768-5. PubMed DOI

Klingel R, Fassbender C, Fassbender T, Erdtracht B, Berrouschot J. Rheopheresis: rheologic, functional, and structural aspects. Ther Apher. 2000;4:348–357. doi: 10.1046/j.1526-0968.2000.004005348.x. PubMed DOI

Blaha M, Andrys C, Langrova H, et al. Changes of the complement system and rheological indicators after therapy with rheohemapheresis. Atheroscler Suppl. 2015;18:140–145. doi: 10.1016/j.atherosclerosissup.2015.02.009. PubMed DOI

Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146:S1–35. doi: 10.1177/0194599812436449. PubMed DOI

Novotny Z, Novak M. Correlation of speech audiometry with the Fowler and Sabin method of hearing loss evaluation. Ceskoslovenska otolaryngologie. 1990;39:146–153. PubMed

Blaha M, Rencova E, Langrova H, et al. Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration. Atheroscler Suppl. 2013;14:179–184. doi: 10.1016/j.atherosclerosissup.2012.10.023. PubMed DOI

Eftekharian A, Amizadeh M. Pulse steroid therapy in idiopathic sudden sensorineural hearing loss: a randomized controlled clinical trial. Laryngoscope. 2016;126:150–155. doi: 10.1002/lary.25244. PubMed DOI

Ullrich H, Kleinjung T, Steffens T, Jacob P, Schmitz G, Strutz J. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J Clin Apher. 2004;19:71–78. doi: 10.1002/jca.20001. PubMed DOI

Bianchin G, Russi G, Romano N, Fioravanti P. Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study. Laryngoscope. 2010;120:800–807. doi: 10.1002/lary.20835. PubMed DOI

Uygun-Kiehne S, Straube R, Heibges A, Klingel R, Davids H. Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy. HNO. 2010;58:445–451. doi: 10.1007/s00106-009-2004-2. PubMed DOI

Chang SL, Hsieh CC, Tseng KS, Weng SF, Lin YS. Hypercholesterolemia is correlated with an increased risk of idiopathic sudden sensorineural hearing loss: a historical prospective cohort study. Ear Hear. 2014;35:256–261. doi: 10.1097/AUD.0b013e3182a76637. PubMed DOI

Quaranta N, Squeo V, Sangineto M, Graziano G, Sabba C. High total cholesterol in peripheral blood correlates with poorer hearing recovery in idiopathic sudden sensorineural hearing loss. PLoS One. 2015;10:e0133300. doi: 10.1371/journal.pone.0133300. PubMed DOI PMC

Lee JS, Kim DH, Lee HJ, et al. Lipid profiles and obesity as potential risk factors of sudden sensorineural hearing loss. PLoS One. 2015;10:e0122496. doi: 10.1371/journal.pone.0122496. PubMed DOI PMC

Wittig J, Wittekindt C, Kiehntopf M, Guntinas-Lichius O. Prognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing loss. BMC Ear Nose Throat Disord. 2014;14:6. doi: 10.1186/1472-6815-14-6. PubMed DOI PMC

Zhao H, Zhang TY, Jing JH, Fu YY, Luo JN. Prognostic factors for patients with the idiopathic sudden sensorineural hearing loss. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2008;43:660–664. PubMed

Chien CY, Tai SY, Wang LF, et al. Metabolic syndrome increases the risk of sudden sensorineural hearing loss in Taiwan: a case–control study. Otolaryngol Head Neck Surg. 2015;153:105–111. doi: 10.1177/0194599815575713. PubMed DOI

Fusconi M, Chistolini A, de Virgilio A, et al. Sudden sensorineural hearing loss: a vascular cause? Analysis of prothrombotic risk factors in head and neck. Int J Audiol. 2012;51:800–805. doi: 10.3109/14992027.2012.705904. PubMed DOI

Chang IJ, Kang CJ, Yueh CY, Fang KH, Yeh RM, Tsai YT. The relationship between serum lipids and sudden sensorineural hearing loss: a systematic review and meta-analysis. PLoS One. 2015;10:e0121025. doi: 10.1371/journal.pone.0121025. PubMed DOI PMC

Ciorba A, Hatzopoulos S, Bianchini C, et al. Idiopathic sudden sensorineural hearing loss: cardiovascular risk factors do not influence hearing threshold recovery. Acta Otorhinolaryngol Ital. 2015;35:103–109. PubMed PMC